Anokion Information

View Top Employees from Anokion

Anokion SA is a Swiss biotechnology company that aims to make a meaningful difference in the lives of patients suffering from autoimmune diseases by restoring normal immune tolerance. The company is focused on both prevalent and rare autoimmune diseases, including celiac disease, multiple sclerosis and type 1 diabetes. Anokion’s distinct approach leverages the company’s immune-based platform, which targets natural pathways in the liver to restore immune tolerance and address the underlying cause of autoimmune disease.

Website	http://www.anokion.com
Revenue	$10.4 million
Funding	$75 million
Employees	14 (4 on RocketReach)
Founded	2010
Address	50 Hampshire St, Cambridge, Massachusetts 02139, US
Phone	+1 857-320-6607
Technologies	JavaScript , HTML , PHP +18 more (view full list)
Industry	Biotechnology Research, Pharmaceuticals, Biotechnology, Immunoengineering, Healthcare, Science and Engineering, Protein engineering, Clinical Trials, Biologics, Health Care, Autoimmune diseases, Therapeutics
Web Rank	19 Million
Keywords	Biopharma, Medicine, Autoimmune Diseases, Health, Immunology, Biotechnology, Therapeutics, Drug Discovery, Clinical Trials, Precision Medicine, Rare Diseases, Immunomodulation, Pharmaceutical Research, Biologics, Therapeutic Antibodies, Protein Engineering, Innovative Therapies, Targeted Therapies
Competitors	Novartis, Sanofi, Bristol Myers Squibb, Celerion, Xencor, AbCellera, Provention Bio, a Sanofi Company, NantKwest, TheraTarget, Inc., Immunex Corporation +49 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 6215 Companies, NAICS Code 621 Companies, NAICS Code 5417 Companies, NAICS Code 62 Companies, NAICS Code 54 Companies, NAICS Code 62151 Companies